Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Appendage | 1 | 2023 | 29 | 0.830 |
Why?
|
| Brain Neoplasms | 5 | 2015 | 305 | 0.630 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 805 | 0.480 |
Why?
|
| Meningeal Neoplasms | 5 | 2021 | 58 | 0.430 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 207 | 0.400 |
Why?
|
| Cardiac Catheterization | 3 | 2023 | 252 | 0.400 |
Why?
|
| Meningioma | 4 | 2021 | 59 | 0.350 |
Why?
|
| Choroid Plexus | 1 | 2010 | 16 | 0.340 |
Why?
|
| Hydrocephalus | 1 | 2010 | 43 | 0.330 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2009 | 3 | 0.320 |
Why?
|
| Neoplasms, Neuroepithelial | 1 | 2009 | 5 | 0.320 |
Why?
|
| Teratoma | 1 | 2009 | 11 | 0.320 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2021 | 21 | 0.300 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2008 | 12 | 0.300 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2019 | 74 | 0.270 |
Why?
|
| Brain | 6 | 2022 | 1488 | 0.220 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2023 | 92 | 0.210 |
Why?
|
| Amnesia, Anterograde | 1 | 2022 | 3 | 0.210 |
Why?
|
| Biomarkers, Tumor | 3 | 2021 | 461 | 0.200 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 428 | 0.200 |
Why?
|
| Brain Injuries | 2 | 2022 | 135 | 0.190 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2002 | 39 | 0.190 |
Why?
|
| Chronic Traumatic Encephalopathy | 1 | 2021 | 5 | 0.190 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2002 | 77 | 0.190 |
Why?
|
| Humans | 23 | 2023 | 59360 | 0.190 |
Why?
|
| Methotrexate | 1 | 2002 | 76 | 0.190 |
Why?
|
| Central Nervous System Diseases | 1 | 2002 | 56 | 0.190 |
Why?
|
| Tauopathies | 1 | 2021 | 18 | 0.180 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 91 | 0.180 |
Why?
|
| Mitral Valve | 2 | 2019 | 105 | 0.180 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2021 | 51 | 0.180 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2021 | 84 | 0.160 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2019 | 18 | 0.160 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 277 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 475 | 0.150 |
Why?
|
| Glioma | 3 | 2015 | 102 | 0.140 |
Why?
|
| Microscopy, Confocal | 3 | 2015 | 226 | 0.140 |
Why?
|
| Microvessels | 1 | 2017 | 17 | 0.140 |
Why?
|
| Treatment Outcome | 3 | 2023 | 5284 | 0.140 |
Why?
|
| Immunohistochemistry | 5 | 2007 | 847 | 0.130 |
Why?
|
| Down Syndrome | 1 | 2017 | 47 | 0.130 |
Why?
|
| Alzheimer Disease | 2 | 2017 | 679 | 0.130 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2015 | 8 | 0.120 |
Why?
|
| Demeclocycline | 1 | 2015 | 4 | 0.120 |
Why?
|
| Vascular Malformations | 1 | 2015 | 20 | 0.120 |
Why?
|
| Prostaglandins | 1 | 2014 | 17 | 0.120 |
Why?
|
| Pulmonary Circulation | 1 | 2014 | 27 | 0.120 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 38 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2015 | 2060 | 0.120 |
Why?
|
| Male | 12 | 2022 | 27739 | 0.110 |
Why?
|
| Heart Septum | 1 | 2014 | 55 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 137 | 0.110 |
Why?
|
| Spinal Cord | 1 | 2015 | 195 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 2050 | 0.110 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 92 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 937 | 0.100 |
Why?
|
| Contrast Media | 1 | 2015 | 408 | 0.100 |
Why?
|
| Endocarditis, Bacterial | 1 | 2012 | 31 | 0.100 |
Why?
|
| Middle Aged | 9 | 2022 | 16317 | 0.100 |
Why?
|
| Intracranial Embolism | 1 | 2012 | 39 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 249 | 0.100 |
Why?
|
| Staphylococcal Infections | 1 | 2012 | 122 | 0.090 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2010 | 10 | 0.090 |
Why?
|
| Ventriculostomy | 1 | 2010 | 5 | 0.090 |
Why?
|
| Lateral Ventricles | 1 | 2010 | 8 | 0.090 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2010 | 7 | 0.090 |
Why?
|
| Echoencephalography | 1 | 2010 | 13 | 0.090 |
Why?
|
| Paraparesis | 1 | 2010 | 9 | 0.090 |
Why?
|
| Pituitary Neoplasms | 2 | 2015 | 21 | 0.090 |
Why?
|
| Quadriplegia | 1 | 2010 | 14 | 0.090 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2010 | 30 | 0.080 |
Why?
|
| Hyperplasia | 1 | 2010 | 84 | 0.080 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2010 | 40 | 0.080 |
Why?
|
| Prosthesis-Related Infections | 1 | 2010 | 33 | 0.080 |
Why?
|
| Device Removal | 1 | 2010 | 64 | 0.080 |
Why?
|
| Endoscopy | 1 | 2010 | 98 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2015 | 1782 | 0.080 |
Why?
|
| Female | 10 | 2021 | 30705 | 0.080 |
Why?
|
| Glioblastoma | 2 | 2015 | 155 | 0.080 |
Why?
|
| Corpus Callosum | 1 | 2009 | 40 | 0.080 |
Why?
|
| Reoperation | 1 | 2010 | 272 | 0.080 |
Why?
|
| Sepsis | 1 | 2012 | 272 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 386 | 0.070 |
Why?
|
| Synapsins | 1 | 2007 | 7 | 0.070 |
Why?
|
| Synaptophysin | 1 | 2007 | 6 | 0.070 |
Why?
|
| Plaque, Amyloid | 1 | 2007 | 38 | 0.070 |
Why?
|
| Presenilin-1 | 1 | 2007 | 57 | 0.070 |
Why?
|
| Melanoma | 1 | 2010 | 329 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2006 | 32 | 0.060 |
Why?
|
| Bone Development | 1 | 2006 | 29 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2010 | 1283 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 1479 | 0.060 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2005 | 7 | 0.060 |
Why?
|
| Infant | 1 | 2010 | 1486 | 0.060 |
Why?
|
| Neurilemmoma | 1 | 2005 | 11 | 0.060 |
Why?
|
| Pregnancy | 2 | 2010 | 2202 | 0.060 |
Why?
|
| Neuropeptides | 1 | 2005 | 83 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2005 | 111 | 0.060 |
Why?
|
| Osteoblasts | 1 | 2006 | 195 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 2337 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 1 | 2004 | 19 | 0.060 |
Why?
|
| Central Nervous System Cysts | 1 | 2004 | 2 | 0.060 |
Why?
|
| Diplopia | 1 | 2004 | 9 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 289 | 0.060 |
Why?
|
| Adolescent | 2 | 2015 | 5824 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2022 | 64 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 619 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2004 | 260 | 0.050 |
Why?
|
| Seizures | 1 | 2022 | 113 | 0.050 |
Why?
|
| Injections, Spinal | 1 | 2002 | 44 | 0.050 |
Why?
|
| Rubidium Radioisotopes | 1 | 2021 | 2 | 0.050 |
Why?
|
| Leukemia | 1 | 2002 | 57 | 0.050 |
Why?
|
| Head Injuries, Closed | 1 | 2021 | 14 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 418 | 0.050 |
Why?
|
| Coronary Circulation | 1 | 2021 | 50 | 0.050 |
Why?
|
| Axons | 1 | 2002 | 118 | 0.050 |
Why?
|
| Neoplasm Grading | 1 | 2021 | 79 | 0.040 |
Why?
|
| Survival Rate | 2 | 2014 | 802 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2006 | 1304 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 200 | 0.040 |
Why?
|
| Aged | 4 | 2021 | 13416 | 0.040 |
Why?
|
| Adult | 5 | 2017 | 15669 | 0.040 |
Why?
|
| Prognosis | 2 | 2014 | 1600 | 0.040 |
Why?
|
| Catheterization | 1 | 2019 | 111 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2019 | 209 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 914 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2011 | 250 | 0.040 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2017 | 16 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 257 | 0.030 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2019 | 153 | 0.030 |
Why?
|
| Punctures | 1 | 2015 | 56 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2017 | 286 | 0.030 |
Why?
|
| Mice | 3 | 2021 | 10292 | 0.030 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 24 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2015 | 121 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 188 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 98 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2015 | 68 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 3231 | 0.030 |
Why?
|
| Heart Atria | 1 | 2014 | 135 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 1526 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2015 | 173 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 196 | 0.030 |
Why?
|
| Animals | 4 | 2021 | 19651 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2014 | 459 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 62 | 0.020 |
Why?
|
| California | 1 | 2011 | 159 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1561 | 0.020 |
Why?
|
| Acyclovir | 1 | 2010 | 19 | 0.020 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2010 | 8 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 396 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 300 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2374 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 1921 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2010 | 313 | 0.020 |
Why?
|
| Skeleton | 1 | 2006 | 3 | 0.020 |
Why?
|
| Dentate Gyrus | 1 | 2005 | 11 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2006 | 53 | 0.020 |
Why?
|
| Child | 1 | 2015 | 4174 | 0.020 |
Why?
|
| Massachusetts | 1 | 2011 | 2002 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2005 | 148 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 4267 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2006 | 142 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2006 | 193 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2006 | 115 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 365 | 0.010 |
Why?
|
| Nestin | 1 | 2004 | 13 | 0.010 |
Why?
|
| Ethylnitrosourea | 1 | 2004 | 11 | 0.010 |
Why?
|
| Gliosis | 1 | 2004 | 27 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 584 | 0.010 |
Why?
|
| Cavernous Sinus | 1 | 2004 | 7 | 0.010 |
Why?
|
| Carcinogens | 1 | 2004 | 37 | 0.010 |
Why?
|
| Microtubules | 1 | 2005 | 211 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2004 | 36 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 392 | 0.010 |
Why?
|
| Stem Cells | 1 | 2006 | 255 | 0.010 |
Why?
|
| Headache | 1 | 2004 | 54 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 429 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 6071 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2004 | 259 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 574 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 1206 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2004 | 151 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 676 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 942 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 2093 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 1370 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 1910 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1465 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 2456 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 5128 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2006 | 2902 | 0.010 |
Why?
|